127 related articles for article (PubMed ID: 35674904)
21. Activation of Notch signaling in human tongue carcinoma.
Zhang TH; Liu HC; Zhu LJ; Chu M; Liang YJ; Liang LZ; Liao GQ
J Oral Pathol Med; 2011 Jan; 40(1):37-45. PubMed ID: 20819128
[TBL] [Abstract][Full Text] [Related]
22. Notch signaling in prostate cancer: refining a therapeutic opportunity.
Su Q; Xin L
Histol Histopathol; 2016 Feb; 31(2):149-57. PubMed ID: 26521657
[TBL] [Abstract][Full Text] [Related]
23. Notch1-Snail1-E-cadherin pathway in metastatic hepatocellular carcinoma.
Wang XQ; Zhang W; Lui EL; Zhu Y; Lu P; Yu X; Sun J; Yang S; Poon RT; Fan ST
Int J Cancer; 2012 Aug; 131(3):E163-72. PubMed ID: 22052196
[TBL] [Abstract][Full Text] [Related]
24. Canonical Notch signalling is inactive in urothelial carcinoma.
Greife A; Jankowiak S; Steinbring J; Nikpour P; Niegisch G; Hoffmann MJ; Schulz WA
BMC Cancer; 2014 Aug; 14():628. PubMed ID: 25167871
[TBL] [Abstract][Full Text] [Related]
25. The Notch-1 receptor in prostate tumorigenesis.
O'Brien R; Marignol L
Cancer Treat Rev; 2017 May; 56():36-46. PubMed ID: 28457880
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of PER3 reverses paclitaxel resistance of prostate cancer cells by inhibiting the Notch pathway.
Cai DW; Chen D; Sun SP; Liu ZJ; Liu F; Xian SZ; Wu PS; Kong GQ
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2572-2579. PubMed ID: 29771413
[TBL] [Abstract][Full Text] [Related]
27. Wnt and Notch pathways have interrelated opposing roles on prostate progenitor cell proliferation and differentiation.
Shahi P; Seethammagari MR; Valdez JM; Xin L; Spencer DM
Stem Cells; 2011 Apr; 29(4):678-88. PubMed ID: 21308863
[TBL] [Abstract][Full Text] [Related]
28. Characterization of Notch Signalling Pathway Members in Normal Prostate, Prostatic Intraepithelial Neoplasia (PIN) and Prostatic Adenocarcinoma.
Soylu H; Acar N; Ozbey O; Unal B; Koksal IT; Bassorgun I; Ciftcioglu A; Ustunel I
Pathol Oncol Res; 2016 Jan; 22(1):87-94. PubMed ID: 26341090
[TBL] [Abstract][Full Text] [Related]
29. Notch activation is dispensable for D, L-sulforaphane-mediated inhibition of human prostate cancer cell migration.
Hahm ER; Chandra-Kuntal K; Desai D; Amin S; Singh SV
PLoS One; 2012; 7(9):e44957. PubMed ID: 22970326
[TBL] [Abstract][Full Text] [Related]
30. Meta-analysis reveals the correlation of Notch signaling with non-small cell lung cancer progression and prognosis.
Yuan X; Wu H; Xu H; Han N; Chu Q; Yu S; Chen Y; Wu K
Sci Rep; 2015 May; 5():10338. PubMed ID: 25996086
[TBL] [Abstract][Full Text] [Related]
31. Triptonide effectively suppresses gastric tumor growth and metastasis through inhibition of the oncogenic Notch1 and NF-κB signaling pathways.
Xiang S; Zhao Z; Zhang T; Zhang B; Meng M; Cao Z; Zhou Q
Toxicol Appl Pharmacol; 2020 Feb; 388():114870. PubMed ID: 31866380
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological inhibition of the Notch pathway enhances the efficacy of androgen deprivation therapy for prostate cancer.
Cui J; Wang Y; Dong B; Qin L; Wang C; Zhou P; Wang X; Xu H; Xue W; Fang YX; Gao WQ
Int J Cancer; 2018 Aug; 143(3):645-656. PubMed ID: 29488214
[TBL] [Abstract][Full Text] [Related]
33. NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications.
Clementz AG; Rogowski A; Pandya K; Miele L; Osipo C
Breast Cancer Res; 2011 Jun; 13(3):R63. PubMed ID: 21679465
[TBL] [Abstract][Full Text] [Related]
34. HES6 promotes prostate cancer aggressiveness independently of Notch signalling.
Carvalho FL; Marchionni L; Gupta A; Kummangal BA; Schaeffer EM; Ross AE; Berman DM
J Cell Mol Med; 2015 Jul; 19(7):1624-36. PubMed ID: 25864518
[TBL] [Abstract][Full Text] [Related]
35. Notch signaling pathway and cancer metastasis.
Hu YY; Zheng MH; Zhang R; Liang YM; Han H
Adv Exp Med Biol; 2012; 727():186-98. PubMed ID: 22399348
[TBL] [Abstract][Full Text] [Related]
36. Dynamics of notch expression during murine prostate development and tumorigenesis.
Shou J; Ross S; Koeppen H; de Sauvage FJ; Gao WQ
Cancer Res; 2001 Oct; 61(19):7291-7. PubMed ID: 11585768
[TBL] [Abstract][Full Text] [Related]
37. The Notch signaling pathway in head and neck squamous cell carcinoma: A meta-analysis.
Zhao YY; Yu GT; Xiao T; Hu J
Adv Clin Exp Med; 2017 Aug; 26(5):881-887. PubMed ID: 29068587
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
Liu X; Luo X; Wu Y; Xia D; Chen W; Fang Z; Deng J; Hao Y; Yang X; Zhang T; Zhou L; Wu Y; Wang Q; Xu J; Hu X; Li L
Cell Physiol Biochem; 2018; 50(1):261-276. PubMed ID: 30282072
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
[TBL] [Abstract][Full Text] [Related]
40. Notch signaling dynamics in the adult healthy prostate and in prostatic tumor development.
Pedrosa AR; Graça JL; Carvalho S; Peleteiro MC; Duarte A; Trindade A
Prostate; 2016 Jan; 76(1):80-96. PubMed ID: 26419726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
